No Data
Sunshine Novo: Third Quarter Report 2024
Third Quarter Report 2024
Sun-Nor(688621.SH): Net income in the first three quarters was 0.208 billion yuan, a year-on-year increase of 21.4%.
Gelonghui October 28th | Sunshine Norh Pharmaceutical (688621.SH) announced the third quarter report for 2024, with the company's revenue for the first three quarters of 0.917 billion yuan, a year-on-year increase of 32.47%; net income attributable to shareholders of the listed company was 0.208 billion yuan, a year-on-year increase of 21.4%; basic earnings per share was 1.85 yuan.
Yangguang Nuohuo (688621.SH) announced its performance for the first three quarters, with a net income of 0.208 billion yuan, an increase of 21.40% year-on-year.
Sunno Pharmaceutical (688621.SH) disclosed its third quarter report for 2024, achieving operating income in the first three quarters...
Sun-Nor Pharmaceuticals (688621.SH): Shengpu Medicine has cumulatively completed the purchase of 0.35% shares.
Gelonghui October 10th | Yangguang Nuowei (688621.SH) announced that from April 1, 2024 to September 30, 2024, Shengpu Medicine has cumulatively completed the purchase of a total of 0.3972 million shares through centralized bidding, accounting for 0.35% of the company's total share capital, with a purchase amount of 16 million yuan, reaching 50% of the upper limit of the total amount of shares to be purchased this time. Based on the confidence in the company's future sustainable and stable development and the recognition of its long-term investment value, in response to investor concerns and actively fulfilling commitments to better protect the interests of the general investors, enhance investor confidence, while being subjected to regulations
YANGGUANG NUOHE (688621.SH): Core technical personnel Xie Daosheng resigned, Nie Aihua was identified as the company's core technical personnel.
On October 7th, Yangguang Nuohuo (688621.SH) announced that the company's core technical personnel Xie Daosheng resigned from his position due to personal reasons and completed relevant departure procedures; after leaving, Xie Daosheng will no longer hold any position in the company or its subsidiaries. Xie Daosheng has signed a "Labor Contract" and a "Confidentiality Agreement" with the company, and the intellectual property rights developed during his tenure with the company are all considered as work achievements, and the relevant ownership belongs to the company or its subsidiaries, without any situation affecting the integrity of the company's intellectual property rights. After Xie Daosheng's departure, the work he was responsible for has been properly handed over, and the company's production operation, technical research and development, and other work are all in order.
No Data
No Data